Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD-286

A demonstrated 100% concordance between biomarker-guided predictions from pre-treatment patient samples and clinical outcomes ...

Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates ...
GEN

Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...
Business Insider

Auron Presents New Preclinical Data for AUTX-703 in AML at ASH Annual Meeting

Data demonstrate dose dependent survival advantage with AUTX-703 in primary patient-derived orthotopic AML model IND submissions on track for late 2024 NEWTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- ...
News Medical

Scientists develop mouse model to gain new insights into genetic mechanisms underlying AML

A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets. Scientists ...
Hosted on MSN

Two drugs that treat prostate cancer may also be effective against leukemia

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn ...